$2.08
0.020.97%
At Close: -
$2.07
-0.0099-0.48%
After Hours: Jul 2, 7:23 PM EDT
15 minutes delayed
Xeris Biopharma Holdings
XERSNASDAQ
Xeris Biopharma Holdings (NASDAQ:XERS) Stock, Earnings Estimates, EPS, And Revenue
Xeris Biopharma Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.140
Quarterly Revenue
$40.6M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$171.4M
Analyze the earnings history of Xeris Biopharma Holdings using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings | -$0.14 | — | — | — | $36.89M | — | — | — | 08/06/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.12 | -$0.12 | -$0.14 | -16.67% | $33.20M | $41.81M | $40.64M | -2.80% | 05/09/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.10 | -$0.10 | -$0.10 | 0.00% | $33.14M | $43.55M | $44.39M | 1.93% | 03/06/2024 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.16 | -$0.12 | -$0.09 | 25.00% | $29.73M | $41.08M | $48.32M | 17.62% | 11/09/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.19 | -$0.13 | -$0.14 | -7.69% | $25.26M | $34.84M | $36.89M | 5.89% | 08/08/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.25 | -$0.17 | -$0.12 | 29.41% | $22.07M | $30.76M | $33.20M | 7.92% | 05/09/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.42 | -$0.16 | -$0.10 | 37.50% | $21.43M | $31.04M | $33.14M | 6.78% | 03/08/2023 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.39 | -$0.16 | -$0.16 | 0.00% | $11.04M | $29.12M | $29.73M | 2.08% | 11/09/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.41 | -$0.20 | -$0.19 | 5.00% | $8.84M | $25.53M | $25.26M | -1.06% | 08/10/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.30 | -$0.25 | -$0.25 | 0.00% | $8.05M | $23.59M | $21.91M | -7.12% | 05/11/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.41 | -$0.24 | -$0.42 | -75.00% | $7.09M | $18.90M | $21.43M | 13.38% | 03/10/2022 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.35 | -$0.37 | -$0.39 | -5.41% | $9.45M | $11.03M | $11.04M | 0.05% | 11/10/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.63 | -$0.30 | -$0.41 | -36.67% | $2.03M | $9.54M | $8.84M | -7.39% | 08/05/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.89 | -$0.34 | -$0.30 | 11.76% | $1.79M | $7.47M | $8.05M | 7.78% | 05/13/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.23 | -$0.38 | -$0.41 | -7.89% | $1.86M | $8.21M | $7.09M | -13.65% | 03/09/2021 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.22 | -$0.52 | -$0.35 | 32.69% | $314.00K | $4.48M | $9.45M | 110.89% | 11/09/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.28 | -$0.73 | -$0.63 | 13.70% | $320.00K | $1.86M | $2.03M | 8.98% | 08/10/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$1.07 | -$0.89 | -$0.89 | 0.00% | $248.00K | $1.43M | $1.79M | 25.03% | 05/07/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.98 | -$1.13 | -$1.23 | -8.85% | $801.00K | $660.00K | $1.86M | 182.42% | 03/11/2020 | Get Alert |
| XERS | Xeris Biopharma Holdings | -$0.71 | — | -$1.22 | — | $582.00K | — | $314.00K | — | 11/07/2019 | Get Alert |
| XERS | Xeris Biopharma Holdings | — | -$0.93 | -$1.28 | -37.63% | — | $50.00K | $320.00K | 540.00% | 08/06/2019 | Get Alert |
Xeris Biopharma Holdings (XERS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.14 | $-0.12 | -16.7 % |
| Dec 2023 | 2024-03-06 | $-0.10 | $-0.10 | 0.00 % |
| Sep 2023 | 2023-11-09 | $-0.09 | $-0.12 | 25.0 % |
| Jun 2023 | 2023-08-08 | $-0.14 | $-0.13 | -7.69 % |
Xeris Biopharma Holdings (XERS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $40.64M | $41.81M | -2.80 % |
| Dec 2023 | 2024-03-06 | $44.39M | $43.55M | 1.93 % |
| Sep 2023 | 2023-11-09 | $48.32M | $41.08M | 17.6 % |
| Jun 2023 | 2023-08-08 | $36.89M | $34.84M | 5.89 % |
FAQ
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings (XERS) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Xeris Biopharma Holdings (NASDAQ:XERS)?
The Actual EPS was $-0.14, which missed the estimate of $-0.12.
What were Xeris Biopharma Holdings’s (NASDAQ:XERS) revenues?
The Actual Revenue was $40.6M, which missed the estimate of $41.8M.
Browse earnings estimates, EPS, and revenue on all stocks.